Investigating Wnt signaling: a chemogenomic safari
Authors:
- Michael KahnMKMichael Kahn
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 10 (21) , 1467-1474
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Small‐Molecule Kinase‐Inhibitor Target AssessmentChemBioChem, 2005
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- β-Catenin signaling is required for neural differentiation of embryonic stem cellsDevelopment, 2004
- The Wnt/β-catenin pathway directs neuronal differentiation of cortical neural precursor cellsDevelopment, 2004
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004
- From large networks to small moleculesCurrent Opinion in Chemical Biology, 2004
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- Validating survivin as a cancer therapeutic targetNature Reviews Cancer, 2003
- The Promise and Perils of Wnt Signaling Through β-CateninScience, 2002
- Use of the Kohonen Self-organizing Map to Study the Mechanisms of Action of Chemotherapeutic AgentsJNCI: Journal of the National Cancer Institute, 1994